Unique Lipoprotein Phenotype and Genotype Associated with Exceptional Longevity

JAMA

Volumn 290, Issue 15, 2003, Pages 2030-2040

  Barzilai, Nir ^a   Atzmon, Gil ^a   Schechter, Clyde ^a   Schaefer, Ernst J ^c   Cupples, Adrienne L ^d   Lipton, Richard ^a   Cheng, Suzanne ^e   Shuldiner, Alan R ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOLEUCINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VALINE; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN;

AGED; AGING; ALLELISM; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CODON; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; JEW; LONGEVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; ONSET AGE; PARTICLE SIZE; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; BLOOD; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; METABOLIC SYNDROME X;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CODON; FEMALE; GENOTYPE; GLYCOPROTEINS; HUMANS; HYPERTENSION; ISOLEUCINE; JEWS; LIPOPROTEINS; LONGEVITY; MALE; METABOLIC SYNDROME X; PARTICLE SIZE; PHENOTYPE; POLYMORPHISM, GENETIC; VALINE;

EID: 0142088521     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.15.2030     Document Type: Article

References (43)

1. Barzilai N, Shuldiner AR. Searching for human longevity genes: the future history of gerontology in the post-genomic era. J Gerontol. 2001;56A:M83-M87.
2. Perls TT, Wilmoth J, Levenson R, et al. Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci U S A. 2002;99:8442-8447.
3. Atzmon G, Schechter C, Greiner W, et al. Clinical phenotype of families with longevity. J Am Geriatr Soc In press.
4. Puca AA, Daly MJ, Brewster SJ, et al. A genomewide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci U S A. 2001;98:10505-10508.
5. Herrera VL, Makrides SC, Xie HX, et al. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat Med. 1999;5:1383-1389.
6. Barzilai N, Gabriely I, Gabriely M, et al. Offspring of centenarians have a favorable lipid profile. J Am Geriatr Soc. 2001;49:76-79.
7. Atzmon G, Gabriely I, Greiner W, et al. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol. 2002;57:M712-M715.
8. Lancaster JM, Carney ME, Futreal PA. BRCA 1 and 2: a genetic link to familial breast and ovarian cancer. Medscape Womens Health. 1997;2:7.
9. Verghese J, Lipton RB, Hall CB, et al. Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med. 2002;347:1761-1768.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
11. Schaefer EJ, Lamon-Fava S, Cohn SD, et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res. 1994;35:779-792.
12. Otvos JD, Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab. 2002;48:171-180.
13. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem. 1992;38:1632-1638.
14. Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 2002;106:1930-1937.
15. Grundy SM, Vega LG, Otvos JD, et al. Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men: genetic and pharmacological evidence. J Lipid Res. 1999; 40:229-234.
16. Cheng S, Grow MA, Pallaud C, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res. 1999;9:936-949.
17. Falconer DS, Mackay TFC. Introduction to Quantitative Genetics. Essex, England: Addison Wesley Longman; 1996.
18. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288: 2709-2716.
19. Yamashita S, Sprecher DL, Sakai N, et al. Accumulation of apolipoprotein E-rich high-density lipo proteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest. 1990;86:688-695.
20. Ikewaki K, Nishiwaki M, Sakamoto T, et al. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest. 1995;96:1573-1581.
21. Sakai N, Yamashita S, Hirano K, et al. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency. Eur J Clin Invest. 1995;25:332-339.
22. Arai T, Tsukada T, Murase T, et al. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency. Clin Chim Acta. 2000;301:103-117.
23. Perls T, Levenson R, Regan M, Puca A. What does it take to live to 100? Mech Ageing Dev. 2002;123: 231-242.
24. Austin MA. Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Curr Atheroscler Rep. 2000;2:200-207.
25. Pascot A, Lemieux I, Bergeron J, et al. HDL particle size: a marker of the gender difference in the metabolic risk profile. Atherosclerosis. 2002;160:399-406.
26. Asztalos BF, Horvath KV, McNamara JR, et al. Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients. J Lipid Res. 2002; 43:1701-1707.
27. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483-1492.
28. Barzilai N, Gupta G. Revisiting the role of fat mass in the life extension induced by caloric restriction. J Gerontol A Biol Sci Med Sci. 1999;54:B89-B96.
29. Libby P. Managing the risk of atherosclerosis: the role of high-density lipoprotein. Am J Cardiol. 2001; 88:3N-8N.
30. Rader DJ, Maugeais C. Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention. Mol Med. 2000;6:170-175.
31. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95:69-75.
32. Garvey WT, Kwon S, Zheng D, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003;52:453-462.
33. Austin MA, Jarvik GP, Hokanson JE, Edwards K. Complex segregation analysis of LDL peak particle diameter. Genet Epidemiol. 1993;10:599-604.
34. Bruce C, Sharp DS, Tall AR. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res. 1998;39:1071-1078.
35. Goto A, Sasai K, Suzuki S, et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis. 2001;159:153-163.
36. Okumura K, Matsui H, Kamiya H, et al. Differential effect of two common polymorphisms in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. Atherosclerosis. 2002;161: 425-431.
37. Gudnason V, Kakko S, Nicaud V, et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations: the EARS group. Eur J Clin Invest. 1999;29:116-128.
38. Kakko S, Tamminen M, Paivansalo M, et al. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men. Eur J Clin Invest. 2000;30:18-25.
39. Kakko S, Tamminen M, Paivansalo M, et al. Variation at the cholesteryl ester transfer protein gene in relation to plasma high-density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest. 2001;31:593-602.
40. Boekholdt SM, Thompson JF. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res. 2003;44:1080-1093.
41. Funke H, Wiebusch H. Fuer L, et al. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high-density lipoprotein cholesterol. Circulation. 1994;90:1-241.
42. Kuivenhoven JA, de Knijff P, Boer JM, et al. Heterogeneity at the CETP gene locus: influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol. 1997;17:560-568.
43. Arai Y, Hirose N, Yamamura K, et al. Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity. J Mol Med. 2003;81: 102-109.